Path2 Hydrogen(PTHH)株式概要フィロマックスキャップAGは、ドイツで投資、金融持ち株、通信、再生可能エネルギー、人工知能、不動産、教育、娯楽事業に従事している。 詳細PTHH ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6報酬当社が推定した公正価値より70%で取引されている リスク分析German市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去5年間で収益は年間70.3%減少しました。 収益が 100 万ドル未満 ( €77K )意味のある時価総額がありません ( €63M )+1 さらなるリスクすべてのリスクチェックを見るPTHH Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.552.2k% 割高 内在価値ディスカウントEst. Revenue$PastFuture-10m1m2016201920222025202620282031Revenue €1.3mEarnings €246.5kAdvancedSet Fair ValueView all narrativesPath2 Hydrogen AG 競合他社ScherzerSymbol: XTRA:PZSMarket cap: €73.2m029 GroupSymbol: DB:Z29Market cap: €200.0mCHAPTERS GroupSymbol: XTRA:CHGMarket cap: €782.0mSamara Asset GroupSymbol: DB:SRAGMarket cap: €114.3m価格と性能株価の高値、安値、推移の概要Path2 Hydrogen過去の株価現在の株価€0.5552週高値€2.4052週安値€0.40ベータ-0.0461ヶ月の変化-7.56%3ヶ月変化-12.70%1年変化-72.36%3年間の変化-23.61%5年間の変化-68.75%IPOからの変化-99.90%最新ニュースお知らせ • Jun 27Philomaxcap AG, Annual General Meeting, Aug 06, 2025Philomaxcap AG, Annual General Meeting, Aug 06, 2025, at 12:00 W. Europe Standard Time.お知らせ • Jun 05Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million.Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million. Security Name: Shares Security Type: Common Stock Securities Offered: 1,184,000 Price\Range: €2 Transaction Features: Subsequent Direct ListingNew Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.3m).New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (€10.2m market cap, or US$11.4m).New Risk • Aug 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 11x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.2m).New Risk • May 05New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€293k free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 2.2% per year over the past 5 years. Revenue is less than US$1m (€161k revenue, or US$174k). Market cap is less than US$10m (€851.4k market cap, or US$916.5k).最新情報をもっと見るRecent updatesお知らせ • Jun 27Philomaxcap AG, Annual General Meeting, Aug 06, 2025Philomaxcap AG, Annual General Meeting, Aug 06, 2025, at 12:00 W. Europe Standard Time.お知らせ • Jun 05Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million.Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million. Security Name: Shares Security Type: Common Stock Securities Offered: 1,184,000 Price\Range: €2 Transaction Features: Subsequent Direct ListingNew Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.3m).New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (€10.2m market cap, or US$11.4m).New Risk • Aug 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 11x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.2m).New Risk • May 05New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€293k free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 2.2% per year over the past 5 years. Revenue is less than US$1m (€161k revenue, or US$174k). Market cap is less than US$10m (€851.4k market cap, or US$916.5k).New Risk • Feb 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€596.7k market cap, or US$642.9k). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).New Risk • Jul 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€339k free cash flow). Share price has been highly volatile over the past 3 months (10% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€942.8k market cap, or US$1.03m).お知らせ • Jun 29+ 1 more updatePhilomaxcap AG Announces CEO Changes with Effect from July 01, 2023Achim Pfeffer (53) becomes new sole member of the board of Philomaxcap AG. The Supervisory Board of Philomaxcap AG has appointed Mr. Achim Pfeffer as the new Chief Executive Officer with effect from July 01, 2023. Achim Pfeffer succeeds the previous sole member of the Executive Board Robert Bidwell Bibow, who resigned from his office for personal reasons as of the end of June 30, 2023.Executive Departure • Jul 13Vice President of the Supervisory Board Andreas Geisler has left the companyOn the 30th of June, Andreas Geisler's tenure as Vice President of the Supervisory Board ended. We don't have any record of a personal shareholding under Andreas' name. A total of 2 executives have left over the last 12 months.Executive Departure • Jun 11Chairman of the Management Board Robert Zeiss has left the companyOn the 31st of May, Robert Zeiss' tenure as Chairman of the Management Board ended. We don't have any record of a personal shareholding under Robert's name. Robert is the only executive to leave the company over the last 12 months.Is New 90 Day High Low • Feb 02New 90-day low: €1.50The company is down 12% from its price of €1.70 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is up 19% over the same period.Is New 90 Day High Low • Dec 10New 90-day high: €2.40The company is up 14% from its price of €2.10 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 11% over the same period.Is New 90 Day High Low • Nov 05New 90-day high: €2.32The company is up 47% from its price of €1.58 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 22% over the same period.Is New 90 Day High Low • Oct 19New 90-day high: €2.24The company is up 59% from its price of €1.41 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 14% over the same period.株主還元PTHHDE Diversified FinancialDE 市場7D-12.0%1.2%2.8%1Y-72.4%-20.4%1.4%株主還元を見る業界別リターン: PTHH過去 1 年間で-20.4 % の収益を上げたGerman Diversified Financial業界を下回りました。リターン対市場: PTHHは、過去 1 年間で1.4 % のリターンを上げたGerman市場を下回りました。価格変動Is PTHH's price volatile compared to industry and market?PTHH volatilityPTHH Average Weekly Movement13.6%Diversified Financial Industry Average Movement5.3%Market Average Movement6.0%10% most volatile stocks in DE Market12.8%10% least volatile stocks in DE Market2.7%安定した株価: PTHHの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: PTHHの 週次ボラティリティ は過去 1 年間で28%から14%に減少しましたが、依然としてGerman株の 75% よりも高くなっています。会社概要設立従業員CEO(最高経営責任者ウェブサイト1997n/aJosh McMorrowpath2hydrogen.comPhilomaxcap AGは、ドイツで投資・金融ホールディング、通信、再生可能エネルギー、人工知能、不動産、教育、エンターテインメント事業に従事している。また、モノのインターネット、農業技術、産業技術、医療技術、スマートホーム建設、eスポーツとエンターテインメント、データエネルギー、製品流通、ブロックチェーン技術事業にも携わっている。旧社名はPhicomm AGで、2020年6月に社名をPhilomaxcap AGに変更した。同社は1997年に設立され、ドイツのミュンヘンを拠点としている。Philomaxcap AGはPhilocity Holdings Sdn Bhdの子会社である。もっと見るPath2 Hydrogen AG 基礎のまとめPath2 Hydrogen の収益と売上を時価総額と比較するとどうか。PTHH 基礎統計学時価総額€63.01m収益(TTM)-€4.70m売上高(TTM)€76.55k801.3xP/Sレシオ-13.1xPER(株価収益率PTHH は割高か?公正価値と評価分析を参照収益と収入最新の決算報告書(TTM)に基づく主な収益性統計PTHH 損益計算書(TTM)収益€76.55k売上原価€116.59k売上総利益-€40.04kその他の費用€4.66m収益-€4.70m直近の収益報告Jun 30, 2025次回決算日該当なし一株当たり利益(EPS)-0.042グロス・マージン-52.31%純利益率-6,137.22%有利子負債/自己資本比率70.5%PTHH の長期的なパフォーマンスは?過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/26 04:00終値2026/05/26 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Path2 Hydrogen AG 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 27Philomaxcap AG, Annual General Meeting, Aug 06, 2025Philomaxcap AG, Annual General Meeting, Aug 06, 2025, at 12:00 W. Europe Standard Time.
お知らせ • Jun 05Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million.Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million. Security Name: Shares Security Type: Common Stock Securities Offered: 1,184,000 Price\Range: €2 Transaction Features: Subsequent Direct Listing
New Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.3m).
New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (€10.2m market cap, or US$11.4m).
New Risk • Aug 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 11x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.2m).
New Risk • May 05New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€293k free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 2.2% per year over the past 5 years. Revenue is less than US$1m (€161k revenue, or US$174k). Market cap is less than US$10m (€851.4k market cap, or US$916.5k).
お知らせ • Jun 27Philomaxcap AG, Annual General Meeting, Aug 06, 2025Philomaxcap AG, Annual General Meeting, Aug 06, 2025, at 12:00 W. Europe Standard Time.
お知らせ • Jun 05Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million.Philomaxcap AG has completed a Follow-on Equity Offering in the amount of €2.368 million. Security Name: Shares Security Type: Common Stock Securities Offered: 1,184,000 Price\Range: €2 Transaction Features: Subsequent Direct Listing
New Risk • Oct 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.3m).
New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m (€20k revenue, or US$22k). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (€10.2m market cap, or US$11.4m).
New Risk • Aug 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 11x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 11x increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€10.2m market cap, or US$11.2m).
New Risk • May 05New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€293k free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 2.2% per year over the past 5 years. Revenue is less than US$1m (€161k revenue, or US$174k). Market cap is less than US$10m (€851.4k market cap, or US$916.5k).
New Risk • Feb 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€596.7k market cap, or US$642.9k). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
New Risk • Jul 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€339k free cash flow). Share price has been highly volatile over the past 3 months (10% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€942.8k market cap, or US$1.03m).
お知らせ • Jun 29+ 1 more updatePhilomaxcap AG Announces CEO Changes with Effect from July 01, 2023Achim Pfeffer (53) becomes new sole member of the board of Philomaxcap AG. The Supervisory Board of Philomaxcap AG has appointed Mr. Achim Pfeffer as the new Chief Executive Officer with effect from July 01, 2023. Achim Pfeffer succeeds the previous sole member of the Executive Board Robert Bidwell Bibow, who resigned from his office for personal reasons as of the end of June 30, 2023.
Executive Departure • Jul 13Vice President of the Supervisory Board Andreas Geisler has left the companyOn the 30th of June, Andreas Geisler's tenure as Vice President of the Supervisory Board ended. We don't have any record of a personal shareholding under Andreas' name. A total of 2 executives have left over the last 12 months.
Executive Departure • Jun 11Chairman of the Management Board Robert Zeiss has left the companyOn the 31st of May, Robert Zeiss' tenure as Chairman of the Management Board ended. We don't have any record of a personal shareholding under Robert's name. Robert is the only executive to leave the company over the last 12 months.
Is New 90 Day High Low • Feb 02New 90-day low: €1.50The company is down 12% from its price of €1.70 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is up 19% over the same period.
Is New 90 Day High Low • Dec 10New 90-day high: €2.40The company is up 14% from its price of €2.10 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 11% over the same period.
Is New 90 Day High Low • Nov 05New 90-day high: €2.32The company is up 47% from its price of €1.58 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 22% over the same period.
Is New 90 Day High Low • Oct 19New 90-day high: €2.24The company is up 59% from its price of €1.41 on 21 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 14% over the same period.